Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wen Wei San Ji Gao is a Traditional Chinese Medicine (TCM) formulation developed by the Shaanxi Provincial Traditional Chinese Medicine Hospital. It is primarily investigated for the treatment of chronic atrophic gastritis (CAG) accompanied by intestinal metaplasia (IM). The formulation's name, which translates to "Stomach-Warming and Nodule-Dissipating Paste," reflects its therapeutic focus on improving gastric mucosal health and resolving precancerous lesions. It is typically administered via acupoint application (topical paste), a method intended to deliver herbal constituents through the skin to influence internal organ function. Clinical research aims to evaluate its efficacy in reversing or stabilizing gastric mucosal atrophy and intestinal metaplasia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wen Wei San Ji Gao.